SCHEMBL30770696

SCHEMBL30770696

CC1=CC(=O)C(C2CCCCCC2)=CC1=O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 1/20 0.52
MAOB P27338 1/20 0.52
APLNR P35414 2/20 0.48
PTPN1 P18031 2/20 0.47
PTPRC P08575 1/20 0.47
PTPRF P10586 1/20 0.47
CDC25B P30305 1/20 0.47
EEF2K O00418 1/20 0.41
PLK1 P53350 1/20 0.41
PLK2 Q9NYY3 1/20 0.41
NR1I2 O75469 1/20 0.35
KDM4B O94953 1/20 0.35
CHRM1 P11229 1/20 0.35
TBXA2R P21731 1/20 0.35
ADRA1A P35348 1/20 0.35
DOHH Q9BU89 1/20 0.35
STAT3 P40763 1/20 0.34
DAO P14920 1/20 0.32
JAK2 O60674 1/20 0.30
JAK1 P23458 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10782026 1.00 MAOA (0.52) MAOAMAOBAPLNRPTPN1PTPRC
SCHEMBL30770693 0.98 MAOA (0.53) MAOAMAOBAPLNRPTPN1PTPRC
SCHEMBL10781942 0.87 MAOA (0.64) MAOAMAOBAPLNRPTPN1PTPRC
SCHEMBL8749597 0.76 MAOA (0.52) MAOAMAOBAPLNRPTPN1PTPRC
SCHEMBL6532441 0.73 MAOA (0.48) MAOAMAOBAPLNRPTPN1PTPRC
SCHEMBL31495256 0.72 PTPN1 (0.47) MAOAMAOBAPLNRPTPN1PTPRC
SCHEMBL11679425 0.71 PTPN1 (0.35) MAOAMAOBAPLNRPTPN1PTPRC
SCHEMBL29266041 0.71 MAOA (0.96) MAOAMAOBAPLNRPTPN1PTPRC
SCHEMBL9343961 0.71 MAOA (0.96) MAOAMAOBAPLNRPTPN1PTPRC
SCHEMBL19386509 0.71 PTPN1 (0.46) MAOAMAOBAPLNRPTPN1PTPRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024003428-A1 QUINONE-DERIVED COMPOUNDS AND USE THEREOF AGAINST LEISHMANIA SPP UNIVERSIDAD DE LA LAGUNA (ES) 2024-01-04 WO claimed
US-20260022089-A1 QUINONE-DERIVED COMPOUNDS AND USE THEREOF AGAINST LEISHMANIA SPP UNIVERSIDAD DE LA LAGUNA (ES) 2026-01-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260022089-A1 QUINONE-DERIVED COMPOUNDS AND USE THEREOF AGAINST LEISHMANIA SPP G6PD, SDHA, DHPS MAOA 937/4885MAOB 1177/4885APLNR 3782/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.